We are dedicated to finding a cure for autoimmune diabetes through pharmaceutical development and investments in medical and stem cell technology.
Sweden
Joined August 2009
- Tweets1.7K
- Following123
- Followers861
- Likes321
Nu publicerad: Retogatein från Diamyd Medical fördröjer behovet av insulin med mer än fem år i den randomiserade, placebokontrollerade diabetespreventiva Immune Tolerance-studien diamyd.com/se/pressClips.asp…
Now published: Retogatein from Diamyd Medical delays the need for insulin by more than five years in the randomized, placebo-controlled diabetes prevention – Immune Tolerance Trial diamyd.com/docs/pressClips.a…
Diamyds retogatein fördröjer insulinberoende typ 1-diabetes i mer än fem år diamyd.com/se/pressClips.asp…
Diamyd’s retogatein delays insulin requiring Type-1 Diabetes for more than 5 years diamyd.com/docs/pressClips.a…
ASSET-samarbetet, lett av Diamyd Medical, avslutar femårigt innovationsprogram med slutkonferens om precisionsmedicin och framtidens screening diamyd.com/se/pressClips.asp…
ASSET partnership, coordinated by Diamyd Medical, concludes five-year innovation program with final conference on precision medicine and the future of screening diamyd.com/docs/pressClips.a…
#Diamyd Medical ger en uppdatering om lärdomar från interimsanalysen i DIAGNODE-3 diamyd.com/se/pressClips.asp…
#Diamyd Medical Provides Update on Learnings from DIAGNODE-3 Interim Analysis diamyd.com/docs/pressClips.a…
#Diamyd Medical meddelar uppdatering kring strategisk översyn diamyd.com/se/pressClips.asp…
#Diamyd Medical meddelar uppdatering kring interim CFO diamyd.com/se/pressClips.asp…
#Diamyd Medical announces update regarding interim CFO diamyd.com/docs/pressClips.a…
#Diamyd Medical erhåller Notice of Allowance för Precisionsmedicin-patent diamyd.com/se/pressClips.asp…
#Diamyd Medical receives Notice of Allowance for Key Precision Medicine Patent diamyd.com/docs/pressClips.a…